← back to search

Zhan Chen

Nantong University · CN
Area of research
Computer Vision and Pattern Recognition · Genetics
Research interest
Research focused on Artificial intelligence and Peroxisome proliferator-activated receptor gamma, with related work in Ryanodine receptor 2, Mendelian randomization, PI3K/AKT/mTOR pathway. Notable publications include 'Contrastive Learning from Extremely Augmented Skeleton Sequences for Self-Supervised Action Recognition', 'Relationship of <em>PPARG</em>, <em>PPARGC1A</em>, and <em>PPARGC1B</em> polymorphisms with susceptibility to hepatocellular carcinoma in an...', and 'Ryanodine receptor 2 (RYR2) dysfunction activates the unfolded protein response and perturbs cardiomyocyte maturation'.
h-index
citations
240
works
6
NIH funding
primary concept
email

Recent publications

The drug-elicitable alternative splicing module for tunable vector expression in the heart
Nature Cardiovascular Research 2025cited by 8position: firstdoi
The risk prediction model for acute urine retention after perineal prostate biopsy based on the LASSO approach and Boruta feature selection
Frontiers in Oncology 2025cited by 4position: middledoi
Evidence for a causal effect of major depressive disorder, anxiety on prostatitis risk: A univariate and multivariate Mendelian randomization study
The Prostate 2023cited by 21position: middledoi
Contrastive Learning from Extremely Augmented Skeleton Sequences for Self-Supervised Action Recognition
Proceedings of the AAAI Conference on Artificial Intelligence 2022cited by 164position: middledoi
Ryanodine receptor 2 (RYR2) dysfunction activates the unfolded protein response and perturbs cardiomyocyte maturation
Cardiovascular Research 2022cited by 28position: middledoi
Dual inhibition of DNA-PKcs and mTOR by CC-115 potently inhibits human renal cell carcinoma cell growth
Aging 2020cited by 13position: middledoi
Relationship of <em>PPARG</em>, <em>PPARGC1A</em>, and <em>PPARGC1B</em> polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
OncoTargets and Therapy 2018cited by 30position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yueyang Zhang · Shandong University2 papers (2022–2025)Bing Zheng · Nanchang University2 papers (2020–2025)William T. Pu · World Wide Web Consortium2 papers (2022–2025)Jiangang Chen · Nantong University1 papers (2023–2023)Lei Miao · University of North Carolina at Chapel Hill1 papers (2025–2025)Mengyuan Liu · Macau University of Science and Technology1 papers (2022–2022)Da‐Zhi Wang · Tongji Hospital1 papers (2022–2022)Xiaoran Zhang · Weifang Medical University1 papers (2022–2022)Hua Zhu · Nantong University1 papers (2023–2023)Lemin Zheng · Putian University1 papers (2025–2025)Jing Zhou · Jiangsu University1 papers (2025–2025)Rui Peng · Guangzhou University of Chinese Medicine1 papers (2023–2023)Xinfeng Chen · Medical College of Wisconsin1 papers (2020–2020)Donghua Gu · Nantong University1 papers (2020–2020)Mingming Zhao · National Institutes of Health1 papers (2022–2022)Weili Zhu · Wenzhou Medical University1 papers (2020–2020)Siyang Xu · Nantong University1 papers (2023–2023)Yuhan Yang · Nanjing University of Chinese Medicine1 papers (2025–2025)Zhenmin Liu · Nantong University1 papers (2023–2023)Jiakai Jiang · Nanjing Medical University1 papers (2018–2018)